- Health
-
Pandemics & Infectious Diseases
Medical Treatment & Drug Development
Bacteria & Other Microorganisms
Antimicrobials, Antibiotics & Drug Resistances
Biotech- and Nanotechnology
Post-Doctoral Fellowships
Israel
Studying multi-drug resistance implications of the 'excludon', a novel antisense-based regulatory structure in bacteria
As bacterial resistance to antibiotics is growing, Dr. Ofir Cohen aims to tackle this serious problem by exploiting a recently discovered switch mechanism capable of turning off certain bacterial genes. In particular, it seems to control genes associated with multi-drug resistance. By cataloguing these switches and their functions in multiple microorganisms, Cohen has shown that they are widespread across species and could provide an avenue to treat infections caused by dangerous bacteria that have already become resistant.
Getting the Better of Antibiotic Resistance
To add or modify information on this page, please contact us at the following address: [email protected]
Ofir
COHEN
Institution
Weizmann Institute of Science
Country
Israel
Nationality
Israeli
Related publications
Health
Health Technologies
Medical Treatment & Drug Development
Biotech- and Nanotechnology
Drug Delivery
France
Abolishing frontiers between fundamental science and medicine : building on the potential of biomedical ultrasound
Read more
Mickaël
TANTER